Empirical assessment of biases in cerebrospinal fluid biomarkers of Alzheimer's disease: an umbrella review and re-analysis of data from meta-analyses. — Dong Young Jeong (2021) | RDL Network
Empirical assessment of biases in cerebrospinal fluid biomarkers of Alzheimer's disease: an umbrella review and re-analysis of data from meta-analyses.
Article 2021 en
Authors
DJ
Dong Young Jeong
JL
Jinseok Lee
JK
Jong Yeob Kim
Abstract
1 min read
Our results suggest that there is an excess of statistically significant results and significant biases in the literature of CSF biomarkers for AD. Therefore, the results of CSF biomarkers should be interpreted with caution.
Lazaros Belbasis, Cristiano A. Köhler, Nikos C. Stefanis, Brendon Stubbs, Jim van Os, Eduard Vieta, Mary V. Seeman, Celso Arango, André F. Carvalho, Εvangelos Εvangelou
André F. Carvalho, Cristiano A. Köhler, Brisa S. Fernandes, João Quevedo, Kamilla Woznica Miskowiak, André R. Brunoni, Rodrigo Machado‐Vieira, Michael Maes, Eduard Vieta, Michael Berk
Abbas F. Almulla, Thitiporn Supasitthumrong, Arisara Amrapala, Chavit Tunvirachaisakul, Al-Karrar Kais Abdul Jaleel, Gregory F. Oxenkrug, Hussein Kadhem Al‐Hakeim, Michael Maes
Patrizia Fanara, Po‐yin Anne Wong, Kristofor H. Husted, Shanshan Liu, Victoria M. Liu, Lori A. Kohlstaedt, Timothy Riiff, Joan C. Protasio, Drina Boban, Salena Killion, Maudi Killian, Lorrie Epling, Elisabeth Sinclair, Julia Peterson, Richard W. Price, Deborah E. Cabin, Robert L. Nussbaum, Jörg Brühmann, Roland Brandt, Chadwick W. Christine, Michael J. Aminoff, Marc Hellerstein
Discussion(0)
No comments yet. Be the first to comment.